S&P 500   4,285.52 (-1.20%)
DOW   33,680.14 (-0.96%)
QQQ   355.10 (-1.25%)
AAPL   172.68 (-1.93%)
MSFT   311.68 (-1.85%)
META   298.77 (-0.68%)
GOOGL   127.64 (-2.65%)
AMZN   127.00 (-3.25%)
TSLA   247.45 (+0.19%)
NVDA   422.47 (+0.06%)
NIO   8.56 (+2.51%)
BABA   86.34 (-1.01%)
AMD   96.64 (-0.76%)
T   14.97 (-0.60%)
F   12.53 (-0.40%)
MU   68.63 (+0.07%)
CGC   0.98 (+4.31%)
GE   110.70 (-0.91%)
DIS   80.41 (-0.74%)
AMC   8.33 (+2.33%)
PFE   32.67 (-0.94%)
PYPL   58.96 (+0.17%)
NFLX   383.68 (-0.29%)
S&P 500   4,285.52 (-1.20%)
DOW   33,680.14 (-0.96%)
QQQ   355.10 (-1.25%)
AAPL   172.68 (-1.93%)
MSFT   311.68 (-1.85%)
META   298.77 (-0.68%)
GOOGL   127.64 (-2.65%)
AMZN   127.00 (-3.25%)
TSLA   247.45 (+0.19%)
NVDA   422.47 (+0.06%)
NIO   8.56 (+2.51%)
BABA   86.34 (-1.01%)
AMD   96.64 (-0.76%)
T   14.97 (-0.60%)
F   12.53 (-0.40%)
MU   68.63 (+0.07%)
CGC   0.98 (+4.31%)
GE   110.70 (-0.91%)
DIS   80.41 (-0.74%)
AMC   8.33 (+2.33%)
PFE   32.67 (-0.94%)
PYPL   58.96 (+0.17%)
NFLX   383.68 (-0.29%)
S&P 500   4,285.52 (-1.20%)
DOW   33,680.14 (-0.96%)
QQQ   355.10 (-1.25%)
AAPL   172.68 (-1.93%)
MSFT   311.68 (-1.85%)
META   298.77 (-0.68%)
GOOGL   127.64 (-2.65%)
AMZN   127.00 (-3.25%)
TSLA   247.45 (+0.19%)
NVDA   422.47 (+0.06%)
NIO   8.56 (+2.51%)
BABA   86.34 (-1.01%)
AMD   96.64 (-0.76%)
T   14.97 (-0.60%)
F   12.53 (-0.40%)
MU   68.63 (+0.07%)
CGC   0.98 (+4.31%)
GE   110.70 (-0.91%)
DIS   80.41 (-0.74%)
AMC   8.33 (+2.33%)
PFE   32.67 (-0.94%)
PYPL   58.96 (+0.17%)
NFLX   383.68 (-0.29%)
S&P 500   4,285.52 (-1.20%)
DOW   33,680.14 (-0.96%)
QQQ   355.10 (-1.25%)
AAPL   172.68 (-1.93%)
MSFT   311.68 (-1.85%)
META   298.77 (-0.68%)
GOOGL   127.64 (-2.65%)
AMZN   127.00 (-3.25%)
TSLA   247.45 (+0.19%)
NVDA   422.47 (+0.06%)
NIO   8.56 (+2.51%)
BABA   86.34 (-1.01%)
AMD   96.64 (-0.76%)
T   14.97 (-0.60%)
F   12.53 (-0.40%)
MU   68.63 (+0.07%)
CGC   0.98 (+4.31%)
GE   110.70 (-0.91%)
DIS   80.41 (-0.74%)
AMC   8.33 (+2.33%)
PFE   32.67 (-0.94%)
PYPL   58.96 (+0.17%)
NFLX   383.68 (-0.29%)
Positive News SentimentPositive News
NASDAQ:PRVB

Provention Bio (PRVB) Earnings Date, Estimates & Call Transcripts

Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$24.98
▼
$25.00
50-Day Range
$23.74
▼
$24.98
52-Week Range
$3.18
▼
$25.00
Volume
9.12 million shs
Average Volume
2.28 million shs
Market Capitalization
$2.37 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$22.83
ProfileAnalyst RatingsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainability
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

PRVB Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

PRVB Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Provention Bio Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20231($0.39)($0.39)($0.39)
Q2 20231($0.39)($0.39)($0.39)
Q3 20231($0.30)($0.30)($0.30)
Q4 20231($0.24)($0.24)($0.24)
FY 20234($1.32)($1.32)($1.32)

Provention Bio Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
3/29/2023Q4 2022($0.31)($0.38)($0.07)($0.38)$7.23 million$10.81 million
11/3/2022Q3 2022($0.46)($0.34)+$0.12($0.34)$0.88 million$0.76 million
8/4/2022Q2 2022($0.49)($0.46)+$0.03($0.46)$0.80 million$0.75 million    
5/5/2022Q1 2022($0.45)($0.35)+$0.10($0.35)$0.73 million$0.58 million
2/24/2022Q4 2021($0.44)($0.41)+$0.03($0.41)$0.71 million$0.72 million    
11/4/2021Q3 2021($0.51)($0.43)+$0.08($0.43)$3.75 million$0.68 million    
8/5/2021Q2 2021($0.51)($0.46)+$0.05($0.46)--  
5/6/2021Q1 2021($0.48)($0.52)($0.04)($0.52)--  
2/24/2021Q4 2020($0.50)($0.58)($0.08)($0.58)--  
11/5/2020Q3 2020($0.40)($0.56)($0.16)($0.56)--  












Provention Bio Earnings - Frequently Asked Questions

How much revenue does Provention Bio generate each year?

Provention Bio (NASDAQ:PRVB) has a recorded annual revenue of $12.90 million.

How much profit does Provention Bio generate each year?

Provention Bio (NASDAQ:PRVB) has a recorded net income of -$113.57 million. PRVB has generated -$1.53 earnings per share over the last four quarters.

What is Provention Bio's EPS forecast for next year?

Provention Bio's earnings are expected to grow from ($1.72) per share to ($0.42) per share in the next year.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:PRVB) was last updated on 9/26/2023 by MarketBeat.com Staff

My Account -